Abstract: The disclosed technology relates to a composition and method of increasing the viscosity of a carbon dioxide composition, as well as a method of increasing the production and recovery of hydrocarbons from an underground formation employing the viscosified carbon dioxide composition.

Abstract: Copolymers comprising ethylene, vinyl esters, in particular vinyl acetate and esters of (meth)acrylic acid, selected from esters comprising branched alkyl, cyclic alkyl or optionally alkyl substituted aryl moieties and having a weight average molecular weight of 35,000 g/mol to 120,000 g/mol, formulations of such copolymers in organic solvents and their use as pour point depressant, wax inhibitor and flow enhancer for crude oils.

Abstract: Copolymers comprising ethylene, vinyl esters, in particular vinyl acetate and esters of (meth)acrylic acid, selected from esters comprising branched alkyl, cyclic alkyl or optionally alkyl substituted aryl moieties and having a weight average molecular weight of 35,000 g/mol to 150,000 g/mol, formulations of such copolymers in organic solvents and their use as pour point depressant, wax inhibitor and flow enhancer for crude oils.

Abstract: Copolymers comprising ethylene, vinyl esters, in particular vinyl acetate and esters of (meth)acrylic acid, selected from esters comprising branched alkyl, cyclic alkyl or optionally alkyl substituted aryl moieties and having a weight average molecular weight of 35,000 g/mol to 150,000 g/mol, formulations of such copolymers in organic solvents and their use as pour point depressant, wax inhibitor and flow enhancer for crude oils.

Abstract: Use of methyl glycine diacetic acid (MGDA) as additive in processes for recovering crude oil and/or gas from subterranean formations, wherein the MGDA is a mixture of L- and D-enantiomers of MGDA or salts thereof, said mixture containing an excess of the respective L-isomer, and the enantiomeric excess (ee) of the L-isomer is in the range of from 10% to 75% Preferably, the process is a processes of acidizing subterranean formations.

Abstract: Copolymers comprising ethylene, vinyl esters, in particular vinyl acetate and esters of (meth)acrylic acid, selected from esters comprising branched alkyl, cyclic alkyl or optionally alkyl substituted aryl moieties and having a weight average molecular weight of 35,000 g/mol to 150,000 g/mol, formulations of such copolymers in organic solvents and their use as pour point depressant, wax inhibitor and flow enhancer for crude oils.

Abstract: A decorative sticker for sports shoes that includes a toe appliqué and a heel appliqué. The toe appliqué includes a semi-circular, rounded tip having a plurality of slits perpendicular to the rounded tip and tapered portions at both corners of the rounded tip. The heel appliqué has a rectangular shape. The toe appliqué and the heel appliqué each include a first surface having a decorative design and a second surface having an adhesive material. The adhesive material is protected by a removable cover layer. The removable cover layer is removed and the adhesive is exposed just prior to affixing the toe appliqué to the rubber toe portion of a sports shoe and the heel appliqué to the rubber heel portion of the sports shoe.

Abstract: The use of certain IL-6-type cytokines for the in vitro maturation of mammalian oocytes is described. The in vitro matured oocytes may be used in in vitro fertilization protocols.

Abstract: Various embodiments of the invention provide human intracellular signaling molecules (INTSIG) and polynucleotides which identify and encode INTSIG. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of INTSIG.

Abstract: The use of certain IL-6-type cytokines for the in vitro maturation of mammalian oocytes is described. The in vitro matured oocytes may be used in in vitro fertilization protocols.

Abstract: The present invention provides purified disease detection and treatment molecule polynucleotides (mddt). Also encompassed are the polypeptides (MDDT) encoded by mddt. The invention also provides for the use of mddt, or complements, oligonucleotides, or fragments thereof in diagnostic assays. The invention further provides for vectors and host cells containing mddt for the expression of MDDT. The invention additionally provides for the use of isolated and purified MDDT to induce anitbodies and to screen libraries of compounds and the use of anti-MDDT antibodies in diagnostic assays. Also provided are microarrays containing mddt and methods of use.

Abstract: This invention relates to nucleic acid and amino acid sequences of human transport proteins and to the use of these sequences in the diagnosis, treatment, and prevention of transport, metabolic, neurological, cardiovascular, reproductive, and immune disorders, and cell proliferative disorders including cancer.

Abstract: The invention provides human cytoskeleton associated proteins (CYSKP) and polynucleotides which identify and encode CYSKP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with expression of CYSKP.

Abstract: The gene encoding the ligninase rLDM.TM. 6 has been cloned and expressed. The ligninases produced via the processes disclosed herein are useful to degrade or modify lignin in pulp operations.

Abstract: The subject invention concerns a novel and superior recombinant DNA expression/secretion system for use in prokaryotic organisms to produce useful proteins. The system can be used to have proteins secreted by an engineered prokaryotic host where normally the proteins are not secreted by the host. Also, when using the expression system, proteins are expressed at much higher levels than when the expression system is not used.

Abstract: The invention concerns novel and useful mutant microbes which are capable of releasing substantial amounts of any of several periplasmic or recombinant proteins into the culture medium when carrying an expressed Kil gene. Though E. coli are exemplified, the invention is broadly applicable to the making of mutants of other microbes, for example, Salmonella, Klebsiella, and Rhizobium. A key feature of the invention is the use of a novel selection procedure employing a plasmid comprising the kil gene.